ES388193A1 - Procedimiento para la preparacion de 5-azapirimidin-nucleo-sidos. - Google Patents

Procedimiento para la preparacion de 5-azapirimidin-nucleo-sidos.

Info

Publication number
ES388193A1
ES388193A1 ES388193A ES388193A ES388193A1 ES 388193 A1 ES388193 A1 ES 388193A1 ES 388193 A ES388193 A ES 388193A ES 388193 A ES388193 A ES 388193A ES 388193 A1 ES388193 A1 ES 388193A1
Authority
ES
Spain
Prior art keywords
silylated
alkylated
group
sugar residue
azapyrimidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES388193A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of ES388193A1 publication Critical patent/ES388193A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES388193A 1970-03-14 1971-02-12 Procedimiento para la preparacion de 5-azapirimidin-nucleo-sidos. Expired ES388193A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2012888A DE2012888C3 (de) 1970-03-14 1970-03-14 Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden

Publications (1)

Publication Number Publication Date
ES388193A1 true ES388193A1 (es) 1973-05-01

Family

ID=5765475

Family Applications (1)

Application Number Title Priority Date Filing Date
ES388193A Expired ES388193A1 (es) 1970-03-14 1971-02-12 Procedimiento para la preparacion de 5-azapirimidin-nucleo-sidos.

Country Status (19)

Country Link
US (1) US3817980A (enExample)
JP (1) JPS5527077B1 (enExample)
AT (1) AT313481B (enExample)
BE (1) BE764179A (enExample)
CA (1) CA946379A (enExample)
CH (1) CH552606A (enExample)
CS (1) CS162741B2 (enExample)
DE (1) DE2012888C3 (enExample)
DK (1) DK152134C (enExample)
ES (1) ES388193A1 (enExample)
FI (1) FI56018C (enExample)
FR (1) FR2085707B1 (enExample)
GB (1) GB1351003A (enExample)
HU (1) HU164144B (enExample)
IL (1) IL36363A (enExample)
NL (1) NL180835C (enExample)
PL (1) PL81543B1 (enExample)
SE (1) SE405253B (enExample)
ZA (1) ZA711084B (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1531469A (en) * 1975-12-18 1978-11-08 Farmaceutici Italia Daunosamine nucleosides
US4171431A (en) * 1976-08-19 1979-10-16 The Upjohn Company Nucleosides and process
DE2721466A1 (de) * 1977-05-12 1978-11-16 Robugen Gmbh Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
DE2757365A1 (de) * 1977-12-20 1979-06-21 Schering Ag Neues verfahren zur herstellung von nucleosiden
GB1601020A (en) 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
US4423212A (en) * 1980-12-18 1983-12-27 The Upjohn Company Nucleosides and process
US5099010A (en) * 1983-01-17 1992-03-24 Research Corporation Intermediates in the preparation of 3'-amino-2',3'-dideoxycytidine and the pharmacologically acceptable salts thereof
JPS60193997A (ja) * 1984-03-14 1985-10-02 Sumitomo Chem Co Ltd 新規シアノイミダゾ−ルリボヌクレオシド誘導体およびその製造法
US4730512A (en) * 1984-10-23 1988-03-15 Toyota Jidosha Kabushiki Kaisha Engine crankshaft structure
CA1301166C (en) * 1987-07-21 1992-05-19 John Nicholas Freskos Process for preparing 2-deoxynucleosides
US6982253B2 (en) * 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
AU2003278904A1 (en) * 2002-09-24 2004-04-19 Kornis Pharmaceuticals, Incorporated 1, 3, 5-triazines for treatment of viral diseases
AU2012209018B2 (en) * 2003-03-17 2015-04-02 Celgene International Sarl Methods for isolating crystalline Form I of 5-azacytidine
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
AU2013200662B2 (en) * 2003-03-17 2015-04-02 Celgene International Sarl Methods for isolating crystalline Form I of 5-azacytidine
US7038038B2 (en) 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US20060128654A1 (en) * 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of cytidine analogs and derivatives
US20060128653A1 (en) * 2004-12-10 2006-06-15 Chunlin Tang Pharmaceutical formulation of decitabine
BRPI0817234A2 (pt) * 2007-09-26 2014-09-30 Sinai School Medicine Análogos de azacitidina e seus usos
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
HUE055911T2 (hu) 2008-05-15 2021-12-28 Celgene Corp Citidin-analógokat tartalmazó orális készítmények, és eljárások azok alkalmazására
WO2010014883A2 (en) 2008-08-01 2010-02-04 Dr. Reddy's Laboratories Ltd. Azacitidine process and polymorphs
EP2324042B1 (en) 2008-08-06 2012-11-28 Sicor, Inc. Process for preparing azacytidine intermediate
AU2009279461B2 (en) 2008-08-08 2014-01-23 Scinopharm Taiwan, Ltd. Process for making 5-azacytosine nucleosides and their derivatives
AU2010228982B2 (en) * 2009-03-23 2015-05-14 Ambit Biosciences Corporation Methods of treatment using combination therapy
US20100249394A1 (en) * 2009-03-26 2010-09-30 Albemarle Corporation Processes for producing decitabine
IT1399195B1 (it) 2010-03-30 2013-04-11 Chemi Spa Processo per la sintesi di azacitidina e decitabina
JP6289361B2 (ja) 2011-03-31 2018-03-07 セルジーン インターナショナル サルル ５−アザシチジンの合成
NZ700073A (en) 2012-04-04 2016-08-26 Halozyme Inc Combination therapy with an anti - hyaluronan agent and a tumor - targeted taxane
CN103884809B (zh) * 2013-08-28 2016-01-27 鲁南制药集团股份有限公司 一种地西他滨中间体的分析检测方法
WO2017183215A1 (ja) * 2016-04-21 2017-10-26 大原薬品工業株式会社 ５－アザシチジン類の糖部シリルエーテル誘導体
CN108226309B (zh) 2016-12-13 2020-06-16 江苏奥赛康药业有限公司 一种右丙亚胺的分析方法
CN108239128B (zh) * 2016-12-23 2019-03-29 江苏奥赛康药业股份有限公司 β-核苷类化合物的制备方法
CN110128485B (zh) * 2018-02-09 2022-06-07 鲁南制药集团股份有限公司 一种阿扎胞苷的制备方法
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20
CN114634540B (zh) * 2020-12-15 2026-04-21 鲁南制药集团股份有限公司 一种α异构体制备地西他滨的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1244790B (de) * 1963-10-29 1967-07-20 Ceskoslovenska Akademie Ved Verfahren zur Herstellung des cancerostatisch wirksamen 5-Azacytidins
GB1050899A (enExample) * 1963-12-22
US3328388A (en) * 1964-09-02 1967-06-27 Merck & Co Inc Arabinofuranosyl pyrimidines and methods of preparing same
US3346561A (en) * 1965-10-24 1967-10-10 Merck & Co Inc Pyrimidine 3-deoxynucleosides
US3531464A (en) * 1966-10-21 1970-09-29 Us Health Education & Welfare Alternative synthesis of 2'-deoxy-5-(trifluoromethyl)-uridine and the alphaanomer thereof
CH527207A (de) * 1968-05-08 1972-08-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
CH507969A (de) * 1968-11-12 1971-05-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glycosyl-5-azacytosinen
CH532062A (de) * 1968-11-13 1972-12-31 Ceskoslovenska Akademie Ved Verfahren zur Herstellung von 1-Glykosyl-5-azacytosinen

Also Published As

Publication number Publication date
DE2012888B2 (de) 1980-07-10
FR2085707B1 (enExample) 1975-04-18
SU374828A3 (enExample) 1973-03-20
IL36363A0 (en) 1971-05-26
DK152134C (da) 1988-08-01
JPS5527077B1 (enExample) 1980-07-17
DE2012888C3 (de) 1981-04-02
HU164144B (enExample) 1973-12-28
NL7103459A (enExample) 1971-09-16
NL180835C (nl) 1987-05-04
GB1351003A (en) 1974-04-24
NL180835B (nl) 1986-12-01
FR2085707A1 (enExample) 1971-12-31
CH552606A (de) 1974-08-15
ZA711084B (en) 1971-10-27
CS162741B2 (enExample) 1975-07-15
IL36363A (en) 1974-05-16
AT313481B (de) 1974-02-25
DK152134B (da) 1988-02-01
BE764179A (fr) 1971-09-13
CA946379A (en) 1974-04-30
SE405253B (sv) 1978-11-27
PL81543B1 (enExample) 1975-08-30
FI56018C (fi) 1979-11-12
FI56018B (fi) 1979-07-31
DE2012888A1 (de) 1971-09-30
US3817980A (en) 1974-06-18

Similar Documents

Publication Publication Date Title
ES346177A1 (es) Procedimiento para la preparacion de epipodofilotoxina - bencilideno - d-glucosido.
ES443040A1 (es) Procedimiento para preparar colorantes o-cianoazoicos.
CA960172A (en) Catalytic coal conversion process
CA956850A (en) Direct bonding of electroless metals to substrates
GB1234139A (enExample)
AU466840B2 (en) An amplifier-limited circuit with reduced am to pm conversion
IE35420B1 (en) Amino-s-triazolylbenzenesulphonamides
GB1289918A (enExample)
AU3353271A (en) Improvements inthe attachment of handles to carrier bags
GB1230681A (enExample)
GB1318859A (en) Imidazo-4,5-b-pyridine derivatives
CA817904A (en) Reaction of cyanogen azide with organic compounds free of aliphatic carbon-carbon unsaturation
GB1304164A (enExample)
GB1324612A (en) Epoxy estranes processes for their preparation and compositions incorporating them
ES365986A1 (es) Procedimiento para la obtencion de un antibiotico.
CA954535A (en) Purification of hydrodealkylation reaction vent hydrogen
CA855705A (en) Reaction products of n-3-oxohydrocarbon-substituted acrylamides with active hydrogen compounds
CA969163A (en) Catalyst solution for electroless metal plating
CA843857A (en) Recovery of converter off-gases
CA837119A (en) Ferrocene cyclic thioethers
CA993280A (en) Direct bonding of electroless metals to substrates
CA849009A (en) Silicon derivatives of ferrocene
CA846405A (en) Derived clock from carrier envelope
IL36616A (en) Antiviral compositions containing 1-amino-piperazine derivatives
GB1350671A (en) Adenosine-5,-carboxylate derivatives

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19840223